{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:43:02Z","timestamp":1761831782623,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jacl.2023.01.004","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T11:14:25Z","timestamp":1674731665000},"page":"281-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of triglyceride-rich lipoproteins on early in-stent neoatherosclerosis formation in patients undergoing statin treatment"],"prefix":"10.1016","volume":"17","author":[{"given":"Rikuo","family":"Sakai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Sekimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Koba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taito","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshiro","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seita","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Shinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2023.01.004_bib0001","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2023.01.004_bib0002","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","article-title":"Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment","volume":"36","author":"Otsuka","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2023.01.004_bib0003","doi-asserted-by":"crossref","first-page":"e1366","DOI":"10.4244\/EIJY15M12_05","article-title":"The impact of in-stent neoatherosclerosis on long-term clinical outcomes: an observational study from the Kobe University Hospital optical coherence tomography registry","volume":"12","author":"Kuroda","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacl.2023.01.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001878","article-title":"Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation","volume":"8","author":"Lee","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacl.2023.01.004_bib0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4244\/EIJV9I8A158","article-title":"Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis","volume":"9","author":"Lee","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacl.2023.01.004_bib0006","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ahj.2015.06.005","article-title":"Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation","volume":"170","author":"Kim","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacl.2023.01.004_bib0007","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.amjcard.2014.01.401","article-title":"Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial)","volume":"113","author":"Larsen","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2023.01.004_bib0008","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2023.01.004_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","article-title":"Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges","volume":"14","author":"Sampson","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2023.01.004_bib0010","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2023.01.004_bib0011","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res."},{"key":"10.1016\/j.jacl.2023.01.004_bib0012","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0735-1097(01)01799-5","article-title":"Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound","volume":"39","author":"Jang","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2023.01.004_bib0013","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2011.10.909","article-title":"In-stent neoatherosclerosis: a final common pathway of late stent failure","volume":"59","author":"Park","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2023.01.004_bib0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1373\/clinchem.2010.149559","article-title":"Development of a homogeneous assay for measurement of small dense LDL cholesterol","volume":"57","author":"Ito","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2023.01.004_bib0015","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/2047487319887578","article-title":"Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease","volume":"27","author":"Elshazly","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2023.01.004_bib0016","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/eurheartj\/ehl413","article-title":"Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography","volume":"28","author":"Matsumoto","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2023.01.004_bib0017","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","article-title":"Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation","volume":"59","author":"Tearney","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2023.01.004_bib0018","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2023.01.004_bib0019","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Tg, Hdl Working Group of the Exome Sequencing Project NHL, Blood I, et\u00a0al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2023.01.004_bib0020","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1373\/clinchem.2008.103234","article-title":"Increased plasma apolipoprotein C-III concentration independently predicts cardiovascular mortality: the Hoorn Study","volume":"54","author":"Scheffer","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2023.01.004_bib0021","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/ATVBAHA.117.309007","article-title":"Apolipoprotein C-III levels and incident coronary artery disease risk: The EPIC-Norfolk PROSPECTIVE POPULATION STudy","volume":"37","author":"van Capelleveen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2023.01.004_bib0022","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12944-020-01293-9","article-title":"Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study","volume":"19","author":"Katzmann","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2023.01.004_bib0023","doi-asserted-by":"crossref","DOI":"10.5551\/jat.60152","article-title":"Small dense low-density lipoprotein cholesterol: a residual risk for rapid progression of non-culprit coronary lesion in patients with acute coronary syndrome","author":"Sekimoto","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2023.01.004_bib0024","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11883-019-0791-9","article-title":"Emerging evidence that ApoC-III inhibitors provide novel options to reduce the residual CVD","volume":"21","author":"Taskinen","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2023.01.004_bib0025","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/eurheartj\/ehab820","article-title":"Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk","volume":"43","author":"Tardif","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2023.01.004_bib0026","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1253\/circj.CJ-19-0047","article-title":"Remnant lipoproteins are residual risk factor for future cardiovascular events in patients with stable coronary artery disease and on-statin low-density lipoprotein cholesterol levels <70 mg\/dL","volume":"83","author":"Fujihara","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jacl.2023.01.004_bib0027","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1373\/clinchem.2015.253757","article-title":"Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease","volume":"62","author":"Jepsen","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2023.01.004_bib0028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2019.02.019","article-title":"Remnant cholesterol and coronary atherosclerotic plaque burden assessed by computed tomography coronary angiography","volume":"284","author":"Lin","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.01.004_bib0029","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein B and Non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients","volume":"77","author":"Johannesen","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2023.01.004_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2023.01.004_bib0031","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.amjcard.2012.05.027","article-title":"Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography","volume":"110","author":"Yonetsu","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2023.01.004_bib0032","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jcmg.2012.01.024","article-title":"Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT","volume":"5","author":"Kim","year":"2012","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.jacl.2023.01.004_bib0033","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000357612","article-title":"Assessment of characteristics of neointimal hyperplasia after drug-eluting stent implantation in patients with diabetes mellitus: an optical coherence tomography analysis","volume":"128","author":"Tian","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.jacl.2023.01.004_bib0034","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCIMAGING.112.976167","article-title":"Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry","volume":"5","author":"Yonetsu","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacl.2023.01.004_bib0035","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1536\/ihj.21-015","article-title":"Non-fasting hypertriglyceridemia as an independent risk factor for coronary in-stent restenosis after primary bare metal stent implantation in patients with coronary artery disease","volume":"62","author":"Yoshimura","year":"2021","journal-title":"Int Heart J"},{"key":"10.1016\/j.jacl.2023.01.004_bib0036","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.atherosclerosis.2015.01.026","article-title":"Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent","volume":"239","author":"Ito","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.01.004_bib0037","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jcin.2015.02.020","article-title":"Comparison of Neoatherosclerosis and neovascularization between patients with and without diabetes: an optical coherence tomography study","volume":"8","author":"Gao","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacl.2023.01.004_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.856111","article-title":"GLP-1 receptor agonists and coronary arteries: from mechanisms to events","volume":"13","author":"Pahud de Mortanges","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacl.2023.01.004_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1008922","article-title":"Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials","volume":"9","author":"Scisciola","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacl.2023.01.004_bib0040","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1194\/jlr.R082271","article-title":"Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding","volume":"59","author":"Sniderman","year":"2018","journal-title":"J Lipid Res"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:38:00Z","timestamp":1761831480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287423000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1933287423000211"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2023.01.004","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of triglyceride-rich lipoproteins on early in-stent neoatherosclerosis formation in patients undergoing statin treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2023.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}